Consortium for Intracranial Metastasis Academic Research
CIMARa (Consortium for Intracranial Metastasis Academic Research), formalized in June 2021, is an inclusive group of multidisciplinary clinical investigators, research scientists, and advocates who share the collective goal of improving outcomes for patients with BrM. CIMARa aims to improve outcomes through the development, coordination, and awareness of multi-institutional clinical trials testing novel therapeutic agents for this unique patient population, alongside the translation of preclinical research to the clinical setting 1)
1)
Anders CK, Van Swearingen AED, Neman J, Joyce JA, Cittelly DM, Valiente M, Zimmer AS, Floyd SR, Dhakal A, Sengupta S, Ahluwalia MS, Nagpal S, Kumthekar PU, Emerson S, Basho R, Beal K, Moss NS, Razis ED, Yang JT, Sammons SL, Sahebjam S, Tawbi HA. Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patient with brain metastases. Neurooncol Adv. 2025 Mar 4;7(1):vdaf049. doi: 10.1093/noajnl/vdaf049. PMID: 40276376; PMCID: PMC12019957.